| Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study MJ Cuesta, AM Sánchez-Torres, B Cabrera, M Bioque, ... Schizophrenia Research 164 (1-3), 65-73, 2015 | 115 | 2015 |
| Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis M Bioque, MP García-Portilla, C García-Rizo, B Cabrera, A Lobo, ... Schizophrenia Research 193, 188-196, 2018 | 75 | 2018 |
| Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis L Pina-Camacho, Á Del Rey-Mejías, J Janssen, M Bioque, ... Schizophrenia bulletin 42 (2), 344-357, 2016 | 71 | 2016 |
| The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study G Mezquida, B Cabrera, M Bioque, S Amoretti, A Lobo, A González-Pinto, ... Schizophrenia Research 189, 84-90, 2017 | 59 | 2017 |
| Modelling gene-environment interaction in first episodes of psychosis M Bernardo, M Bioque, B Cabrera, A Lobo, A González-Pinto, L Pina, ... Schizophrenia research 189, 181-189, 2017 | 54 | 2017 |
| Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis? A Ballesteros, AM Sánchez-Torres, JM López-Ilundain, B Cabrera, A Lobo, ... Psychological medicine 48 (13), 2247-2256, 2018 | 53 | 2018 |
| A pharmacovigilance study in first episode of psychosis: psychopharmacological interventions and safety profiles in the PEPs project M Bioque, A Llerena, B Cabrera, G Mezquida, A Lobo, A González-Pinto, ... International Journal of Neuropsychopharmacology 19 (4), pyv121, 2016 | 47 | 2016 |
| Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes S Mas, P Gassó, A Lafuente, M Bioque, A Lobo, A Gonzàlez-Pinto, ... The pharmacogenomics journal 16 (5), 439-445, 2016 | 43 | 2016 |
| Premorbid IQ subgroups in first episode non affective psychosis patients: Long-term sex differences in function and neurocognition R Ayesa-Arriola, E Setién-Suero, KD Neergaard, ÀA Belzunces, ... Schizophrenia research 197, 370-377, 2018 | 41 | 2018 |
| Persistent negative symptoms in first-episode psychosis: early cognitive and social functioning correlates and differences between early and adult onset O Puig, I Baeza, E de la Serna, B Cabrera, G Mezquida, M Bioque, ... The Journal of Clinical Psychiatry 78 (9), 14131, 2017 | 39 | 2017 |
| Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study AM Sánchez-Torres, L Moreno-Izco, R Lorente-Omeñaca, B Cabrera, ... European archives of psychiatry and clinical neuroscience 268, 699-711, 2018 | 37 | 2018 |
| Opposite cannabis-cognition associations in psychotic patients depending on family history A González-Pinto, I González-Ortega, S Alberich, S Ruiz de Azúa, ... PloS one 11 (8), e0160949, 2016 | 36 | 2016 |
| Affective versus non-affective first episode psychoses: A longitudinal study C Torrent, M Reinares, A Martinez-Arán, B Cabrera, S Amoretti, I Corripio, ... Journal of affective disorders 238, 297-304, 2018 | 34 | 2018 |
| Cannabis use, COMT, BDNF and age at first-episode psychosis A Mané, D Bergé, MJ Penzol, M Parellada, M Bioque, A Lobo, ... Psychiatry Research 250, 38-43, 2017 | 34 | 2017 |
| Emotional intelligence in non-psychotic first-degree relatives of people with schizophrenia A Albacete, C Bosque, N Custal, JM Crespo, E Gilabert, A Albiach, ... Schizophrenia research 175 (1-3), 103-108, 2016 | 33 | 2016 |
| Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum … G Mezquida, R Penadés, B Cabrera, G Savulich, A Lobo, ... European Psychiatry 38, 61-69, 2016 | 26 | 2016 |
| Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients S Mas, P Gassó, M Torra, M Bioque, A Lobo, A González-Pinto, ... European Neuropsychopharmacology 27 (7), 647-656, 2017 | 20 | 2017 |
| Counterfactual reasoning deficits in schizophrenia patients F Contreras, A Albacete, P Castellví, A Caño, B Benejam, JM Menchón PLoS One 11 (2), e0148440, 2016 | 20 | 2016 |
| Smoking does not impact social and non-social cognition in patients with first episode psychosis T Sánchez-Gutiérrez, MP García-Portilla, M Parellada, J Bobes, A Calvo, ... Schizophrenia research 199, 64-74, 2018 | 19 | 2018 |
| Age-and gender-related differences in brain tissue microstructure revealed by multi-component T2 relaxometry EJ Canales-Rodríguez, S Alonso-Lana, N Verdolini, S Sarró, I Feria, ... Neurobiology of aging 106, 68-79, 2021 | 18 | 2021 |
